Other OTC - Delayed Quote USD

Sinopharm Group Co. Ltd. (SHTDY)

13.46 +0.79 (+6.27%)
At close: April 22 at 3:45 PM EDT
Loading Chart for SHTDY
DELL
  • Previous Close 12.67
  • Open 13.36
  • Bid --
  • Ask --
  • Day's Range 13.35 - 13.49
  • 52 Week Range 11.35 - 18.01
  • Volume 5,675
  • Avg. Volume 11,900
  • Market Cap (intraday) 8.403B
  • Beta (5Y Monthly) 0.83
  • PE Ratio (TTM) 6.60
  • EPS (TTM) 2.04
  • Earnings Date --
  • Forward Dividend & Yield 0.57 (4.27%)
  • Ex-Dividend Date Jun 15, 2023
  • 1y Target Est --

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. operates as a subsidiary of Sinopharm Industrial Investment Co., Ltd.

www.sinopharmgroup.com.cn

115,959

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SHTDY

Performance Overview: SHTDY

Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

SHTDY
3.17%
HANG SENG INDEX
1.28%

1-Year Return

SHTDY
19.91%
HANG SENG INDEX
16.17%

3-Year Return

SHTDY
2.30%
HANG SENG INDEX
41.48%

5-Year Return

SHTDY
18.77%
HANG SENG INDEX
43.83%

Compare To: SHTDY

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SHTDY

Valuation Measures

Annual
As of 4/22/2024
  • Market Cap

    8.37B

  • Enterprise Value

    9.74B

  • Trailing P/E

    6.60

  • Forward P/E

    6.30

  • PEG Ratio (5yr expected)

    2.36

  • Price/Sales (ttm)

    0.10

  • Price/Book (mrq)

    0.80

  • Enterprise Value/Revenue

    0.02

  • Enterprise Value/EBITDA

    0.43

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.52%

  • Return on Assets (ttm)

    3.73%

  • Return on Equity (ttm)

    13.03%

  • Revenue (ttm)

    596.57B

  • Net Income Avi to Common (ttm)

    9.05B

  • Diluted EPS (ttm)

    2.04

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    63.81B

  • Total Debt/Equity (mrq)

    61.32%

  • Levered Free Cash Flow (ttm)

    6.64B

Company Insights: SHTDY

People Also Watch